Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $454,918 | 120 | 59.3% |
| Consulting Fee | $188,933 | 58 | 24.6% |
| Travel and Lodging | $75,076 | 228 | 9.8% |
| Food and Beverage | $26,142 | 399 | 3.4% |
| Honoraria | $19,210 | 10 | 2.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,610 | 1 | 0.3% |
| Education | $21.23 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $340,013 | 364 | $0 (2022) |
| Galderma Laboratories, L.P. | $196,909 | 206 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $114,622 | 82 | $0 (2019) |
| ABBVIE INC. | $26,107 | 43 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $23,623 | 13 | $0 (2024) |
| Horizon Therapeutics plc | $20,155 | 31 | $0 (2023) |
| Solta Medical, a division of Bausch Health US, LLC | $12,180 | 4 | $0 (2021) |
| Osmotica Pharmaceutical Corp. | $9,249 | 3 | $0 (2020) |
| Amgen Inc. | $7,553 | 5 | $0 (2024) |
| Oyster Point Pharma, Inc. | $5,855 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,440 | 32 | Galderma Laboratories, L.P. ($19,188) |
| 2023 | $50,631 | 86 | ABBVIE INC. ($25,239) |
| 2022 | $153,330 | 138 | Allergan, Inc. ($118,323) |
| 2021 | $111,538 | 80 | Allergan, Inc. ($54,492) |
| 2020 | $47,653 | 33 | Allergan, Inc. ($13,244) |
| 2019 | $177,806 | 172 | Allergan Inc. ($80,402) |
| 2018 | $133,477 | 190 | Galderma Laboratories, L.P. ($53,550) |
| 2017 | $62,034 | 88 | Allergan Inc. ($33,818) |
All Payment Transactions
819 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $132.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | Galderma Laboratories, L.P. | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 11/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Ophthalmology | ||||||
| 10/28/2024 | Galderma Laboratories, L.P. | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 10/28/2024 | Galderma Laboratories, L.P. | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 10/15/2024 | Oyster Point Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $91.56 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $94.32 | General |
| 09/10/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $62.50 | General |
| 06/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/31/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $59.11 | General |
| 05/31/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/30/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $147.97 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/08/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $127.49 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/27/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Ophthalmology | ||||||
| 03/24/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $125.27 | General |
| 03/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $175.00 | General |
| 03/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Ophthalmology | ||||||
| 03/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $33.85 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $119.63 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $131.79 | General |
| Category: Ophthalmology | ||||||
| 02/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Ophthalmology | ||||||
| 02/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 320 | 365 | $121,365 | $27,568 |
| 2022 | 7 | 302 | 349 | $149,329 | $33,607 |
| 2021 | 8 | 308 | 345 | $108,764 | $25,990 |
| 2020 | 5 | 196 | 231 | $37,864 | $8,613 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 19 | 19 | $59,138 | $12,888 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 111 | 153 | $29,529 | $7,953 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 26 | 26 | $7,774 | $2,076 | 26.7% |
| 67840 | Removal of growth of eyelid | Facility | 2023 | 13 | 13 | $8,154 | $1,358 | 16.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 24 | 24 | $7,296 | $1,348 | 18.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $5,577 | $1,171 | 21.0% |
| 92081 | Exam of visual field with limited testing | Facility | 2023 | 49 | 50 | $3,000 | $584.70 | 19.5% |
| 92285 | Photography of content of eyes | Facility | 2023 | 67 | 69 | $897.00 | $190.08 | 21.2% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 31 | 31 | $96,488 | $21,153 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 124 | 168 | $32,424 | $8,512 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 34 | 34 | $10,336 | $2,393 | 23.2% |
| 67875 | Temporary closure of eyelids by suture | Facility | 2022 | 12 | 12 | $5,380 | $589.62 | 11.0% |
| 92081 | Exam of visual field with limited testing | Facility | 2022 | 45 | 46 | $2,760 | $576.13 | 20.9% |
| 92082 | Exam of visual field with intermediate testing | Facility | 2022 | 18 | 18 | $1,422 | $272.63 | 19.2% |
| 92285 | Photography of content of eyes | Facility | 2022 | 38 | 40 | $520.00 | $111.15 | 21.4% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2021 | 17 | 17 | $52,913 | $12,329 | 23.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 125 | 160 | $30,880 | $8,583 | 27.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 35 | 35 | $10,640 | $2,215 | 20.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 14 | $4,186 | $1,145 | 27.4% |
| 67875 | Temporary closure of eyelids by suture | Facility | 2021 | 11 | 11 | $5,194 | $700.06 | 13.5% |
| 92081 | Measurement of field of vision during daylight conditions, limited examination | Facility | 2021 | 52 | 53 | $3,180 | $642.73 | 20.2% |
| 92082 | Measurement of field of vision during daylight conditions, intermediate examination | Facility | 2021 | 15 | 16 | $1,264 | $266.70 | 21.1% |
| 92285 | Photography of content of eyes | Facility | 2021 | 39 | 39 | $507.00 | $108.36 | 21.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 80 | 114 | $21,963 | $5,087 | 23.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 36 | 36 | $10,944 | $2,391 | 21.8% |
About Dr. Wendy Lee, MD
Dr. Wendy Lee, MD is a Ophthalmology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306979620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wendy Lee, MD has received a total of $766,909 in payments from pharmaceutical and medical device companies, with $30,440 received in 2024. These payments were reported across 819 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($454,918).
As a Medicare-enrolled provider, Lee has provided services to 1,126 Medicare beneficiaries, totaling 1,290 services with total Medicare billing of $95,779. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmic Plastic and Reconstructive Surgery
- Location Miami, FL
- Active Since 03/14/2007
- Last Updated 06/23/2016
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1306979620
Products in Payments
- ACTHAR (Biological) $138,245
- BOTOX (Biological) $129,336
- TEPEZZA (Drug) $18,459
- BOTOX COSMETIC (Biological) $13,223
- TEPEZZA (Biological) $7,553
- TYRVAYA (Drug) $3,855
- KYBELLA (Biological) $2,744
- Cequa (Drug) $735.70
- Hydrus (Device) $467.13
- DAXXIFY (Drug) $305.34
- Xeomin (Biological) $286.09
- XEOMIN (Biological) $226.80
- VUITY (Drug) $223.09
- RESTASIS (Drug) $216.13
- XDEMVY (Drug) $153.48
- INVELTYS (Drug) $138.94
- Hydrus Microstent (Device) $137.30
- XIIDRA (Drug) $126.46
- ACTIVEFOCUS (Device) $124.93
- IOLMaster 700 (Device) $112.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Miami
Dr. William Trattler, Md, MD
Ophthalmology — Payments: $733,320
Jennifer Loh, M.d, M.D
Ophthalmology — Payments: $516,142
Jayanth Sridhar, M.d, M.D
Ophthalmology — Payments: $412,440
Dr. Kendall Donaldson, Md, MD
Ophthalmology — Payments: $388,097
Dr. Andrew Schimel, M.d, M.D
Ophthalmology — Payments: $371,324
Dr. Thomas Albini, Md, MD
Ophthalmology — Payments: $371,311